Covestor’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Covestor's JAZZ Position: Q2 2026 in Review
Covestor reduced its Jazz Pharmaceuticals (JAZZ) stake by 44% in Q2 2026, selling an estimated $22.3K and leaving 131 shares worth $32K. The position accounts for 0.02% of the portfolio, ranked #1000.
Covestor first reported a position in JAZZ in Q4 2021 and has held it in 19 quarters since. The position peaked at $145K in Q1 2025. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Covestor held 131 shares of Jazz Pharmaceuticals worth $32K as of Q2 2026.
- Covestor sold 102 Jazz Pharmaceuticals shares in Q2 2026, an estimated $22.3K.
- Jazz Pharmaceuticals made up 0.02% of Covestor's portfolio in Q2 2026, its #1000 holding.
- Covestor first reported a position in Jazz Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
- Covestor's Jazz Pharmaceuticals position peaked at $145K in Q1 2025.
- 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.